Navigation Links
Intrinsic Therapeutics' Barricaid and Magellan Spine Technologies' DART to Drive European Annulus Repair Market
Date:6/29/2009

Two new products to allow for additional spine treatments performed during discectomy procedures, according to Millennium Research Group

WALTHAM, Mass., June 29 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, new annulus repair devices that have entered the European spinal implant market will be key factors contributing to market growth through 2013. MRG's European Markets for Spinal Implants 2009 report finds that the annulus repair segment will form a niche market within the European spinal implant market that will exceed $670 million by 2013.

In April 2009, the first annulus repair device became available in Europe when Intrinsic Therapeutics' Barricaid device received CE marking. Later that month, Magellan Spine Technologies' Disc Annular Repair Technology (DART) System was also granted approval. As these and other companies increasingly promote their products and train surgeons to use them, adoption of annulus repair devices will grow rapidly through 2013.

"Through 2013 and beyond, companies will continue their efforts to demonstrate the benefits of combining annulus repair devices with discectomies, namely fewer costly revisions," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "This will not only boost surgeon confidence in the procedures, which at the moment is low because the devices are so new, but it will also encourage governments and regulatory bodies across Europe to grant reimbursement for annulus repair devices because it will reduce the number of expensive discectomy revisions."

The accumulation of clinical evidence and socioeconomic data that displays how governments can save money by reducing discectomy revisions will be supported by the entrance of new competitors, such as Anulex Technologies, the 2008 leader of the US annulus repair market. The growth of leading competitors, such as Intrinsic Therapeutics and Anulex Technologies, will result in additional resources available to promote annulus repair technology to European surgeons and governments. This will drive uptake of annulus repair devices and expand procedure volumes.

MRG's European Markets for Spinal Implants 2009 report provides various segments of the spinal fusion implant market as well as the market for spinal nonfusion treatments, such as interspinous process decompression devices, pedicle screw-based dynamic stabilization systems, artificial discs, nuclear disc prostheses, annulus repair devices, and facet arthroplasty devices. This report allows clients to assess the effects of the economic downturn, plan for the future, tap into deep segmentation, and leverage up-to-date market shares and in-depth qualitative insights for France, Germany, Italy, Spain and the UK.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
2. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
3. Prospect Therapeutics Inc.s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers
4. Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
5. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
6. Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit
7. Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
8. Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
9. Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement
10. Prospect Therapeutics In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3
11. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The ... program for mid-market executives as a kick-off to the fifth annual CEO Connection ... 2017 on the University of Pennsylvania campus, followed by the two-day convention, which ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the ... two year study conducted by the University of Saskatchewan in partnership with PotashCorp, ... potash brine-impacted groundwater. As a part of the study, batch adsorption experiments were ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 percent ... data released today by the American Society for Dermatologic Surgery (ASDS). ... percentage of consumers considering a cosmetic medical procedure has doubled since 2013. , ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017 Datascope Corp. is voluntarily performing ... Corp. for a potential electrical test failure code.     ... PART NUMBER ... CS300 IABP 0998-UC-0446HXX; ... This ...
(Date:6/13/2017)... Ind. , June 13, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that the U.S. Food and Drug ... dated June 3, 2015 relating to its Zhejiang, ... "The successful clearance of the ... manufacturing facility is a measure of the progress ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
Breaking Medicine Technology: